Hangzhou Tigermed Consulting Co., Ltd.
3347Biotechnology
HK$38.00−1.61%As of Oct 29vs prior close
- Market cap
- $596.3M
- P/E (TTM)
- 43.5×
- P/E (FY1)
- 50.3×
- From 52W high
- −2.21%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥7.3B
- Net margin
- 1.25%
Nomior Score
56
Steady ProfileTop 35% of the scored universe
Growth61
Quality61
Value51
Momentum—
Resilience48
Growth
−1.20%revenue a year over 3 fiscal years
YE22 CN¥7.1BLTM CN¥7.3B
Connections
Revenue to profitYE25
13% of revenue became net profit, up 7 pts on a year.